110 results
6-K
EX-99.1
XTLB
X.T.L. Biopharmaceuticals Ltd.
20 Oct 23
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
4:00pm
Rule 5550(a)(2) before such date. However, there can be no assurance that the Company will be able to regain compliance with the Minimum Bid Price
424B3
wsmly94
9 Jun 21
Prospectus supplement
8:06am
POS AM
dm1f7
2 Jun 21
Prospectus update (post-effective amendment)
1:44pm
20-F/A
b17j81ops011qygdq
19 May 21
Annual report (foreign) (amended)
11:30am
20-F/A
EX-12.2
on8dctmgqcofelhl
19 May 21
Annual report (foreign) (amended)
11:30am
20-F/A
EX-12.1
re73nf289 dgvwuo0t1
19 May 21
Annual report (foreign) (amended)
11:30am